Search

everythinglearnresearchcommunity

for

Search:↓

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Apremilast did not work for treating severe alopecia areata.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The summit aimed to speed up finding treatments for alopecia areata.

Finasteride helps female-pattern hair loss.

The model and estimator can predict drug exposure in kidney transplant patients well.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.